SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-215234
Filing Date
2021-07-14
Accepted
2021-07-14 16:08:52
Documents
4
Period of Report
2021-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d185242d8k.htm 8-K 26846
2 EX-10.1 d185242dex101.htm EX-10.1 73558
3 GRAPHIC g185242dsp15.jpg GRAPHIC 3908
4 GRAPHIC g185242dsp5.jpg GRAPHIC 3848
  Complete submission text file 0001193125-21-215234.txt   112622
Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 211090325
SIC: 2834 Pharmaceutical Preparations